ENANTIOMERICALLY PURE ADAMANTANE CARBOXAMIDES FOR THE TREATMENT OF FILOVIRUS INFECTION
申请人:Arisan Therapeutics, Inc.
公开号:US20210171521A1
公开(公告)日:2021-06-10
The compounds of the invention as shown by general structure I, as shown below, are effective in treating filovirus infections.
X is selected from the group consisting of O and H;
R
1
is selected from (C
6
to C
10
) aryl and (C
2
to C
9
) heteroaryl, and
R
2
is selected from (C
1
to C
10
) alkyl, (C
1
to C
10
) alkenyl, (C
1
to C
10
) alkynyl, (C
3
to C
10
) cycloalkyl, and (C
5
to C
10
) cycloalkenyl, and
NR
3a
R
3b
is defined in the specification.
These compounds are effective in treating filovirii infections including Ebolavirus and Marburg virus.